EZH1 and glioblastoma: Glioblastoma-EV-packaged miR-27a-3p could promote M2 macrophage polarization via the EZH1/KDM3A/CTGF axis, and contribute to glioblastoma cell proliferation and motility, thereby increasing GSC tumorigenicity in vivo [50].